Literature DB >> 29699141

What are the risks of the assisted reproductive technologies (ART) and how can they be minimized?

Robert W Rebar1.   

Abstract

Although assisted reproductive technologies (ART) have become established procedures performed around the world, there are still many unanswered questions regarding safety. Possible risks associated with infertility and ART include (1) those inherent to pregnancy, delivery, and childhood; (2) those associated with the infertility itself and its causes; and (3) risks iatrogenic to ART. Although there are many potential risks associated with ART, it has become clear that the major risk is multiple pregnancy and its consequences. Major efforts are warranted to reduce the risk of multiple gestations with IVF, but it is also clear that single-embryo transfer is not the solution in all cases. Moreover, several studies have now documented that perinatal outcomes are somewhat poorer in IVF singleton infants than in spontaneously conceived singletons, but it is not clear if this increased risk is due to the ART or the infertility. Concerns about the impact of abnormalities in genomic imprinting persist at this time, as do risks associated with the culture conditions and even our environment. Only time will tell if children born following ART are at any increased risk of developing certain chronic diseases as they age. In any case, the risks to IVF children and mothers are likely to remain higher than those for children and mothers conceived spontaneously without medical assistance. However, since there have been over 5 million births after ART worldwide, and the vast majority of pregnancies and children have been essentially "normal", it is obvious that any excess risk must be relatively small. The normality of most pregnancies mandates that extreme care be exercised in making any changes to current practice.

Entities:  

Keywords:  ART; Embryo; IVF; Neonatal outcomes; Risk

Year:  2013        PMID: 29699141      PMCID: PMC5904622          DOI: 10.1007/s12522-013-0156-y

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  52 in total

1.  Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2011-12-21       Impact factor: 7.329

2.  Placental weight in singleton pregnancies with and without assisted reproductive technology: a population study of 536,567 pregnancies.

Authors:  C Haavaldsen; T Tanbo; A Eskild
Journal:  Hum Reprod       Date:  2011-12-19       Impact factor: 6.918

3.  Cancer risk in children and young adults conceived by in vitro fertilization.

Authors:  Bengt Källén; Orvar Finnström; Anna Lindam; Emma Nilsson; Karl-Gösta Nygren; Petra Otterblad Olausson
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

Review 4.  Post-neonatal health and development of children born after assisted reproduction: a systematic review of controlled studies.

Authors:  A K Ludwig; A G Sutcliffe; K Diedrich; M Ludwig
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-04-18       Impact factor: 2.435

5.  Extended embryo culture and an increased risk of preterm delivery.

Authors:  Suleena Kansal Kalra; Sarah J Ratcliffe; Kurt T Barnhart; Christos Coutifaris
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

6.  Defects in imprinting and genome-wide DNA methylation are not common in the in vitro fertilization population.

Authors:  Verity F Oliver; Harriet L Miles; Wayne S Cutfield; Paul L Hofman; Jackie L Ludgate; Ian M Morison
Journal:  Fertil Steril       Date:  2011-11-23       Impact factor: 7.329

7.  Three decades of twin births in the United States, 1980-2009.

Authors:  Joyce A Martin; Brady E Hamilton; Michelle J K Osterman
Journal:  NCHS Data Brief       Date:  2012-01

8.  Inter- and intra-individual variation in allele-specific DNA methylation and gene expression in children conceived using assisted reproductive technology.

Authors:  Nahid Turan; Sunita Katari; Leigh F Gerson; Raffi Chalian; Michael W Foster; John P Gaughan; Christos Coutifaris; Carmen Sapienza
Journal:  PLoS Genet       Date:  2010-07-22       Impact factor: 5.917

9.  Epigenotype-phenotype correlations in Silver-Russell syndrome.

Authors:  E L Wakeling; S Abu Amero; M Alders; J Bliek; E Forsythe; S Kumar; D H Lim; F MacDonald; D J Mackay; E R Maher; G E Moore; R L Poole; S M Price; T Tangeraas; C L S Turner; M M Van Haelst; C Willoughby; I K Temple; J M Cobben
Journal:  J Med Genet       Date:  2010-08-03       Impact factor: 6.318

10.  Neonatal and maternal outcomes comparing women undergoing two in vitro fertilization (IVF) singleton pregnancies and women undergoing one IVF twin pregnancy.

Authors:  Antonina Sazonova; Karin Källen; Ann Thurin-Kjellberg; Ulla-Britt Wennerholm; Christina Bergh
Journal:  Fertil Steril       Date:  2012-12-07       Impact factor: 7.329

View more
  3 in total

1.  Protective placental inflammatory and oxidative stress responses are attenuated in the context of twin pregnancy and chorioamnionitis in assisted reproduction.

Authors:  Hayley R Price; Nick Pang; Hugh Kim; Michael W H Coughtrie; Abby C Collier
Journal:  J Assist Reprod Genet       Date:  2022-01-06       Impact factor: 3.412

2.  A microwell culture system that allows group culture and is compatible with human single media.

Authors:  Shoko Ieda; Tomonori Akai; Yoko Sakaguchi; Sumi Shimamura; Atsushi Sugawara; Masahiro Kaneda; Satoko Matoba; Masanori Kagota; Satoshi Sugimura; Hirotsune Kaijima
Journal:  J Assist Reprod Genet       Date:  2018-07-11       Impact factor: 3.412

3.  Protocol of the Fit-For-Fertility study: a multicentre randomised controlled trial assessing a lifestyle programme targeting women with obesity and infertility.

Authors:  Matea Belan; Myriam Gélinas; Belina Carranza-Mamane; Marie-France Langlois; Anne-Sophie Morisset; Stephanie-May Ruchat; Kim Lavoie; Kristi Adamo; Thomas Poder; Frances Gallagher; Marie-Hélène Pesant; Farrah Jean-Denis; Jean-Patrice Baillargeon
Journal:  BMJ Open       Date:  2022-04-19       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.